Public market insider buying at Valeo Pharma (VPH)

Public market insider buying at Valeo Pharma (C:VPH)

100079 Canada Inc., a 10% Holder, acquired 200,000 Common Shares Class A on a direct ownership basis at a price of $0.900 on October 7th, 2021. This represents a $180,000 investment into the company's shares and an account share holdings change of 2.4%.

Valeo Pharma is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Valeo Pharma Inc is a Canada-based specialty pharmaceutical company dedicated to the commercialization of prescription products in Canada. With a focus on neurodegenerative diseases, woman's health, and oncology and supportive care, the Company has a portfolio of products and a platform to manage these products through stages of commercialization. Valeo Pharma Inc. (VPH) has a high amount of executive buying compared to its small-cap peers in the market over the past three months. According to regulatory filings yesterday, one insider has invested a total amount of $180,000.